TW
OGN icon

TrinityPoint Wealth’s Organon & Co OGN Stock Holding History

TrinityPoint Wealth’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,212
Closed -$177K – 301
2023
Q3 		$177K Buy
+10,212
New +$213K 0.04% 278
2021
Q4 		– Sell
-6,167
Closed -$202K – 318
2021
Q3 		$202K Buy
+6,167
New +$197K 0.04% 295

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

TrinityPoint Wealth's OGN Position: Q4 2023 in Review

TrinityPoint Wealth sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 10,212 shares — an estimated $177K sold.

TrinityPoint Wealth first reported a position in OGN in Q3 2021 and held it in 2 quarters. The position peaked at $202K in Q3 2021. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • TrinityPoint Wealth reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • TrinityPoint Wealth sold 10,212 Organon & Co shares in Q4 2023, an estimated $177K.
  • TrinityPoint Wealth first reported a position in Organon & Co in Q3 2021 and held it in 2 quarters.
  • TrinityPoint Wealth's Organon & Co position peaked at $202K in Q3 2021.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on TrinityPoint Wealth's 13F filing for Q4 2023, filed 8 Feb 2024.